{"name":"Abivax S.A.","slug":"abivax-sa","ticker":"","exchange":"","domain":"abivaxsa.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"ABX464","genericName":"ABX464","slug":"abx464","indication":"Inflammatory bowel disease (Crohn's disease)","status":"phase_3"},{"name":"ABX464 Repeated dose","genericName":"ABX464 Repeated dose","slug":"abx464-repeated-dose","indication":"Treatments for autoimmune diseases","status":"phase_1"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ABX196","genericName":"ABX196","slug":"abx196","indication":"Other","status":"phase_1"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"ABX464 Single dose","genericName":"ABX464 Single dose","slug":"abx464-single-dose","indication":"HIV infection","status":"phase_1"}]}],"pipeline":[{"name":"ABX196","genericName":"ABX196","slug":"abx196","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ABX464","genericName":"ABX464","slug":"abx464","phase":"phase_3","mechanism":"ABX464 is a small molecule that modulates RNA splicing to promote the production of anti-inflammatory isoforms of proteins involved in immune regulation.","indications":["Inflammatory bowel disease (Crohn's disease)","HIV infection"],"catalyst":""},{"name":"ABX464 Repeated dose","genericName":"ABX464 Repeated dose","slug":"abx464-repeated-dose","phase":"phase_1","mechanism":"ABX464 is a small molecule antagonist of RARγ","indications":["Treatments for autoimmune diseases"],"catalyst":""},{"name":"ABX464 Single dose","genericName":"ABX464 Single dose","slug":"abx464-single-dose","phase":"phase_1","mechanism":"ABX464 is a small molecule that modulates the RNA splicing process to inhibit HIV replication.","indications":["HIV infection"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":4,"phaseCounts":{"phase_1":3,"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}